Moody’s affirms Erlanger Health System’s ‘Baa2’ rating

Moody’s Investors Service affirmed its “Baa2” revenue bond rating for Chattanooga, Tenn.-based Erlanger Health System, affecting $50 million of rated bonds.

Advertisement

The rating reflects Moody’s expectation that Erlanger will translate market share growth and strong top-line revenue into improved financial performance.

The rating outlook has been revised from positive to stable.

More articles on healthcare finance:

Financial troubles force Texas health system to shut down
Cleveland Clinic’s operating income jumps 76% in Q3
12 health systems with strong finances

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.